NCT03446807 Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism Status WITHDRAWN Phase PHASE2
NCT03225144 Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Status RECRUITING Phase N/A
NCT03080051 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain Status COMPLETED Phase EARLY_PHASE1
NCT03058965 Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain Status COMPLETED Phase EARLY_PHASE1
NCT02985879 A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP) Status TERMINATED Phase PHASE2
NCT02734485 Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy Status COMPLETED Phase NA
NCT02605785 A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy Status RECRUITING Phase NA
NCT02494024 Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Status COMPLETED Phase PHASE1
NCT02460731 Young Plasma Transfusions for Progressive Supranuclear Palsy Status COMPLETED Phase PHASE1
NCT02460094 Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy Status COMPLETED Phase PHASE1